Βeta-laktamaz inhibitörü (Turkish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Βeta-laktamaz inhibitörü" in Turkish language version.

refsWebsite

Global rank Turkish rank

12doi.org

2^nd place

4^th place

12nih.gov

4^th place

11^th place

4web.archive.org

1^st place

3archive.org

6^th place

2fda.gov

447^th place

858^th place

1fhsu.edu

low place

1worldcat.org

5^th place

8^th place

1springer.com

274^th place

453^rd place

archive.org

Georgopapadakou NH (October 1993). "Penicillin-binding proteins and bacterial resistance to beta-lactams". Antimicrobial Agents and Chemotherapy. 37 (10). ss. 2045-53. doi:10.1128/aac.37.10.2045. PMC 192226 $2. PMID 8257121.
Lahiri SD, Mangani S, Durand-Reville T, Benvenuti M, De Luca F, Sanyal G, Docquier JD (June 2013). "Structural insight into potent broad-spectrum inhibition with reversible recyclization mechanism: avibactam in complex with CTX-M-15 and Pseudomonas aeruginosa AmpC β-lactamases". Antimicrobial Agents and Chemotherapy. 57 (6). ss. 2496-505. doi:10.1128/AAC.02247-12. PMC 3716117 $2. PMID 23439634.
Livermore DM (October 1995). "beta-Lactamases in laboratory and clinical resistance". Clinical Microbiology Reviews. 8 (4). ss. 557-84. doi:10.1128/cmr.8.4.557. PMC 172876 $2. PMID 8665470.

doi.org

Essack SY (October 2001). "The development of beta-lactam antibiotics in response to the evolution of beta-lactamases". Pharmaceutical Research. 18 (10). ss. 1391-9. doi:10.1023/a:1012272403776. PMID 11697463.
Georgopapadakou NH (October 1993). "Penicillin-binding proteins and bacterial resistance to beta-lactams". Antimicrobial Agents and Chemotherapy. 37 (10). ss. 2045-53. doi:10.1128/aac.37.10.2045. PMC 192226 $2. PMID 8257121.
Zapun A, Contreras-Martel C, Vernet T (March 2008). "Penicillin-binding proteins and beta-lactam resistance". FEMS Microbiology Reviews. 32 (2). ss. 361-85. doi:10.1111/j.1574-6976.2007.00095.x. PMID 18248419.
Curello J, MacDougall C (July 2014). "Beyond Susceptible and Resistant, Part II: Treatment of Infections Due to Gram-Negative Organisms Producing Extended-Spectrum β-Lactamases". The Journal of Pediatric Pharmacology and Therapeutics. 19 (3). ss. 156-64. doi:10.5863/1551-6776-19.3.156. PMC 4187532 $2. PMID 25309145.
Wolter DJ, Lister PD (2013). "Mechanisms of β-lactam resistance among Pseudomonas aeruginosa". Current Pharmaceutical Design. 19 (2). ss. 209-22. doi:10.2174/13816128130203. PMID 22894618.
Lahiri SD, Mangani S, Durand-Reville T, Benvenuti M, De Luca F, Sanyal G, Docquier JD (June 2013). "Structural insight into potent broad-spectrum inhibition with reversible recyclization mechanism: avibactam in complex with CTX-M-15 and Pseudomonas aeruginosa AmpC β-lactamases". Antimicrobial Agents and Chemotherapy. 57 (6). ss. 2496-505. doi:10.1128/AAC.02247-12. PMC 3716117 $2. PMID 23439634.
Drawz SM, Bonomo RA (January 2010). "Three decades of beta-lactamase inhibitors". Clinical Microbiology Reviews. 23 (1). ss. 160-201. doi:10.1128/CMR.00037-09. PMC 2806661 $2. PMID 20065329.
Biedenbach D, Bouchillon S, Hackel M, Hoban D, Kazmierczak K, Hawser S, Badal R (February 2015). "Dissemination of NDM metallo-β-lactamase genes among clinical isolates of Enterobacteriaceae collected during the SMART global surveillance study from 2008 to 2012". Antimicrobial Agents and Chemotherapy. 59 (2). ss. 826-30. doi:10.1128/AAC.03938-14. PMC 4335866 $2. PMID 25403666.
Watson ID, Stewart MJ, Platt DJ (September 1988). "Clinical pharmacokinetics of enzyme inhibitors in antimicrobial chemotherapy". Clinical Pharmacokinetics. 15 (3). ss. 133-64. doi:10.2165/00003088-198815030-00001. PMID 3052984.
Hazra S, Xu H, Blanchard JS (June 2014). "Tebipenem, a new carbapenem antibiotic, is a slow substrate that inhibits the β-lactamase from Mycobacterium tuberculosis". Biochemistry. 53 (22). ss. 3671-8. doi:10.1021/bi500339j. PMC 4053071 $2. PMID 24846409.
Livermore DM (October 1995). "beta-Lactamases in laboratory and clinical resistance". Clinical Microbiology Reviews. 8 (4). ss. 557-84. doi:10.1128/cmr.8.4.557. PMC 172876 $2. PMID 8665470.
Leonard DA, Bonomo RA, Powers RA (November 2013). "Class D β-lactamases: a reappraisal after five decades". Accounts of Chemical Research. 46 (11). ss. 2407-15. doi:10.1021/ar300327a. PMC 4018812 $2. PMID 23902256.

fda.gov

"FDA approves new treatment for complicated urinary tract and complicated intra-abdominal infections". Food and Drug Administration. 17 Temmuz 2019. 20 Kasım 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Temmuz 2019.
"FDA approves new antibacterial drug" (Basın açıklaması). Food and Drug Administration. 29 Ağustos 2017. 23 Nisan 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Temmuz 2019.

fhsu.edu

"Beta-Lactamase Inhibitors". Department of Nursing of the Fort Hays State University College of Health and Life Sciences. October 2000. 27 Eylül 2007 tarihinde kaynağından arşivlendi. Erişim tarihi: 17 Ağustos 2007.

nih.gov

ncbi.nlm.nih.gov

Essack SY (October 2001). "The development of beta-lactam antibiotics in response to the evolution of beta-lactamases". Pharmaceutical Research. 18 (10). ss. 1391-9. doi:10.1023/a:1012272403776. PMID 11697463.
Georgopapadakou NH (October 1993). "Penicillin-binding proteins and bacterial resistance to beta-lactams". Antimicrobial Agents and Chemotherapy. 37 (10). ss. 2045-53. doi:10.1128/aac.37.10.2045. PMC 192226 $2. PMID 8257121.
Zapun A, Contreras-Martel C, Vernet T (March 2008). "Penicillin-binding proteins and beta-lactam resistance". FEMS Microbiology Reviews. 32 (2). ss. 361-85. doi:10.1111/j.1574-6976.2007.00095.x. PMID 18248419.
Curello J, MacDougall C (July 2014). "Beyond Susceptible and Resistant, Part II: Treatment of Infections Due to Gram-Negative Organisms Producing Extended-Spectrum β-Lactamases". The Journal of Pediatric Pharmacology and Therapeutics. 19 (3). ss. 156-64. doi:10.5863/1551-6776-19.3.156. PMC 4187532 $2. PMID 25309145.
Wolter DJ, Lister PD (2013). "Mechanisms of β-lactam resistance among Pseudomonas aeruginosa". Current Pharmaceutical Design. 19 (2). ss. 209-22. doi:10.2174/13816128130203. PMID 22894618.
Lahiri SD, Mangani S, Durand-Reville T, Benvenuti M, De Luca F, Sanyal G, Docquier JD (June 2013). "Structural insight into potent broad-spectrum inhibition with reversible recyclization mechanism: avibactam in complex with CTX-M-15 and Pseudomonas aeruginosa AmpC β-lactamases". Antimicrobial Agents and Chemotherapy. 57 (6). ss. 2496-505. doi:10.1128/AAC.02247-12. PMC 3716117 $2. PMID 23439634.
Drawz SM, Bonomo RA (January 2010). "Three decades of beta-lactamase inhibitors". Clinical Microbiology Reviews. 23 (1). ss. 160-201. doi:10.1128/CMR.00037-09. PMC 2806661 $2. PMID 20065329.
Biedenbach D, Bouchillon S, Hackel M, Hoban D, Kazmierczak K, Hawser S, Badal R (February 2015). "Dissemination of NDM metallo-β-lactamase genes among clinical isolates of Enterobacteriaceae collected during the SMART global surveillance study from 2008 to 2012". Antimicrobial Agents and Chemotherapy. 59 (2). ss. 826-30. doi:10.1128/AAC.03938-14. PMC 4335866 $2. PMID 25403666.
Watson ID, Stewart MJ, Platt DJ (September 1988). "Clinical pharmacokinetics of enzyme inhibitors in antimicrobial chemotherapy". Clinical Pharmacokinetics. 15 (3). ss. 133-64. doi:10.2165/00003088-198815030-00001. PMID 3052984.
Hazra S, Xu H, Blanchard JS (June 2014). "Tebipenem, a new carbapenem antibiotic, is a slow substrate that inhibits the β-lactamase from Mycobacterium tuberculosis". Biochemistry. 53 (22). ss. 3671-8. doi:10.1021/bi500339j. PMC 4053071 $2. PMID 24846409.
Livermore DM (October 1995). "beta-Lactamases in laboratory and clinical resistance". Clinical Microbiology Reviews. 8 (4). ss. 557-84. doi:10.1128/cmr.8.4.557. PMC 172876 $2. PMID 8665470.
Leonard DA, Bonomo RA, Powers RA (November 2013). "Class D β-lactamases: a reappraisal after five decades". Accounts of Chemical Research. 46 (11). ss. 2407-15. doi:10.1021/ar300327a. PMC 4018812 $2. PMID 23902256.

springer.com

adisinsight.springer.com

"Cilastatin/imipenem/relebactam — AdisInsight". Springer International Publishing AG. 31 Mayıs 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 29 Nisan 2016.

web.archive.org

"Beta-Lactamase Inhibitors". Department of Nursing of the Fort Hays State University College of Health and Life Sciences. October 2000. 27 Eylül 2007 tarihinde kaynağından arşivlendi. Erişim tarihi: 17 Ağustos 2007.
"FDA approves new treatment for complicated urinary tract and complicated intra-abdominal infections". Food and Drug Administration. 17 Temmuz 2019. 20 Kasım 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Temmuz 2019.
"Cilastatin/imipenem/relebactam — AdisInsight". Springer International Publishing AG. 31 Mayıs 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 29 Nisan 2016.
"FDA approves new antibacterial drug" (Basın açıklaması). Food and Drug Administration. 29 Ağustos 2017. 23 Nisan 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Temmuz 2019.

worldcat.org

Patrick, Graham L. (2017). An introduction to medicinal chemistry. 6th. Oxford, United Kingdom. ISBN 9780198749691. OCLC 987051883.